Top of this page
Skip navigation, go straight to the content

Our Company Magazine Detail

UCB honoured for work on lupus

  • Posted by

    UCB is delighted to have been recognised by the Lupus Foundation of America (LFA) for our contribution to lupus.

    The Foundation is a US-based organisation focused on research, education and advocacy. UCB was honored at the event with Prof. Dr. Iris Loew-Friedrich receiving the Corporate Leadership Award for the Company’s pioneering research in the development of new treatments for lupus and commitment to improving the quality of life for those living with the chronic disease.

    The 'Evening of Hope National Gala' in New York City was attended by patients, caregivers, researchers and celebrities. To celebrate the event and to raise awareness of lupus, the Empire State Building was illuminated in purple.

    Lupus is a chronic autoimmune disease that can mistakenly recognise the body’s own cells as foreign invaders, creating autoantibodies that attack and destroy healthy tissues. It has a major impact on the lives of those directly affected, as well as on their families and their wider communities.

    Lupus, which primarily affects women of child bearing age, can affect any organ of the body including the skin, joints, heart, lungs and brain. As a result there is a tremendous humanistic and economic toll from this disease impacting a patient’s quality of life, reducing the ability to work, and increasing the use of healthcare resources.

    It is for these reasons that UCB continues to  work to bring new therapies to patients and raise awareness of the disease among the public. We will continue to support the lupus community and are encouraged by the appreciation we have received in return.

  • Like

Leave a Comment